Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

5.3K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

2.5K
2.5K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

Signal transduction and targeted therapy·2026
Same author

Isolation and profiling of single circulating tumor cells in myeloma: a new workflow for liquid biopsies.

BioTechniques·2026
Same author

Thyroid cancer detection and classification using spectral imaging and artificial intelligence.

Scientific reports·2026
Same author

Three-Dimensional Organization of Telomeres: An Emerging Prognostic Biomarker in Multiple Myeloma.

Cells·2025
Same author

Reversine-Induced Telomere Architecture Remodeling in Chronic Myeloid Leukemia Cell Lines: Insights from TeloView<sup>®</sup> Analysis of 3D Nuclear Architecture.

Current issues in molecular biology·2025
Same author

Multiparametric single-cell biophysical cytometry under tunable viscoelastic extensional flows for classification of T-cell lymphomas on their nuclear phenotypes.

Biosensors & bioelectronics·2025

Related Experiment Video

Updated: May 1, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

27.7K

c-MYC-induced genomic instability.

Alexandra Kuzyk1, Sabine Mai

  • 1Manitoba Institute of Cell Biology, University of Manitoba, CancerCare Manitoba, Winnipeg, Manitoba R3E 0V9, Canada.

Cold Spring Harbor Perspectives in Medicine
|April 3, 2014
PubMed
Summary
This summary is machine-generated.

MYC gene dysregulation drives genomic instability, initiating tumor formation. This deregulation is sufficient to cause B-cell neoplasia and affects multiple cellular processes, leading to genomic rearrangements.

More Related Videos

Capturing Common Fragile Site Breaks by Native &#947;H2A.X ChIP
09:46

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP

Published on: January 24, 2025

707
Quantitation and Analysis of the Formation of HO-Endonuclease Stimulated Chromosomal Translocations by Single-Strand Annealing in Saccharomyces cerevisiae
09:40

Quantitation and Analysis of the Formation of HO-Endonuclease Stimulated Chromosomal Translocations by Single-Strand Annealing in Saccharomyces cerevisiae

Published on: September 23, 2011

16.7K

Related Experiment Videos

Last Updated: May 1, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

27.7K
Capturing Common Fragile Site Breaks by Native &#947;H2A.X ChIP
09:46

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP

Published on: January 24, 2025

707
Quantitation and Analysis of the Formation of HO-Endonuclease Stimulated Chromosomal Translocations by Single-Strand Annealing in Saccharomyces cerevisiae
09:40

Quantitation and Analysis of the Formation of HO-Endonuclease Stimulated Chromosomal Translocations by Single-Strand Annealing in Saccharomyces cerevisiae

Published on: September 23, 2011

16.7K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MYC dysregulation is a critical factor in tumor initiation.
  • Early research utilized retroviruses and cell culture to study MYC's role in transformation.
  • Transgenic mouse models confirmed MYC deregulation's sufficiency in causing B-cell neoplasia.

Purpose of the Study:

  • To summarize the role of MYC dysregulation in initiating genomic instability and tumor development.
  • To highlight the impact of MYC on gene regulation, microRNA profiles, and nuclear organization.

Main Methods:

  • Review of early retroviral studies.
  • Analysis of cell culture models.
  • Examination of MYC transgenic mouse models.

Main Results:

  • MYC deregulation alone can initiate B-cell neoplasia in mice.
  • Over 70% of tumors exhibit c-MYC gene dysregulation.
  • Dysregulation impacts gene expression, microRNA profiles, genomic amplifications, and nuclear structure.

Conclusions:

  • MYC dysregulation is a key driver of genomic instability and tumor initiation.
  • These molecular and structural changes facilitate dynamic genomic rearrangements crucial for cellular transformation.